anonymous
Guest
anonymous
Guest
Its time to take decisive action. Time to act man!
An orderly disposal of any VRZ viable assets is the logical next step.
One source assures me that Actavis Allergan have offered VRX $2.5 billion for the entire Bausch and Lomb portfolio.
Not as high as the $8 billion paid by VRX.
But unfortunately vrx IS NOW BUST with little room left to haggle.
To new dynamic VRX board - Please consider accepting it or risk wreckless trading.
No point in risking jail time. Good Luck!
An orderly disposal of any VRZ viable assets is the logical next step.
One source assures me that Actavis Allergan have offered VRX $2.5 billion for the entire Bausch and Lomb portfolio.
Not as high as the $8 billion paid by VRX.
But unfortunately vrx IS NOW BUST with little room left to haggle.
To new dynamic VRX board - Please consider accepting it or risk wreckless trading.
No point in risking jail time. Good Luck!